Novo Nordisk engages Thermo Fisher to produce weight-loss drug
Pharmaceutical Technology
AUGUST 25, 2023
Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the weight-loss drug, Wegovy (semaglutide), Reuters reported.
California’s low-cost insulin plans receive $100m manufacturing boost
Pharmaceutical Technology
JULY 15, 2022
The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. Prices would be “a fraction of the $300 per vial prices charged by insulin manufacturers.”.
Insulin 
328
328 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Contract manufacturer PCI pumps $365M+ into US, EU packaging projects
Fierce Pharma
SEPTEMBER 24, 2024
Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both sides of the Atlantic. |
Arranta Bio set to boost manufacturing for growing pipeline of microbiome drugs
Bio Pharma Dive
SEPTEMBER 30, 2020
The contract manufacturer aims to capitalize on progress for microbiome-based therapies, a field that's been buoyed by some recent clinical successes.
Manufacturing 144
144 
Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program
Fierce Pharma
NOVEMBER 21, 2023
Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR.
The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. The drug was approved to treat type 2 diabetes mellitus in May. million in Q3.
Drugs 264
264 
The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. The drug was approved to treat type 2 diabetes mellitus in May. million in Q3.
Drugs 246
246 
Forge Biologics and Labcorp partner for gene therapies development
Pharmaceutical Technology
MAY 4, 2023
Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. This will improve accessibility to services for AAV-mediated gene therapy programmes.
Gene Therapy 256
256 
ADC (Antibody Drug Conjugates) Contract Manufacturing Market, 2030 – ResearchAndMarkets.com
BioTech 365
JANUARY 5, 2021
ADC (Antibody Drug Conjugates) Contract Manufacturing Market, 2030 – ResearchAndMarkets.com ADC (Antibody Drug Conjugates) Contract Manufacturing Market, 2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “ADC Contract Manufacturing Market (4th Edition) by Phase of Development, Type of Component Manufacturing, Target (..)
4th Edition Market Study into Small Molecule Drug Product Contract Manufacturer Quality – ResearchAndMarkets.com
BioTech 365
JANUARY 15, 2021
4th Edition Market Study into Small Molecule Drug Product Contract Manufacturer Quality – ResearchAndMarkets.com 4th Edition Market Study into Small Molecule Drug Product Contract Manufacturer Quality – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Small Molecule Drug Product Contract Manufacturer Quality Benchmarking (..)
Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality
Roots Analysis
AUGUST 29, 2023
Over the last few decades, the development landscape of small molecule drugs has been significantly impacted by various biotechnology breakthroughs. As a result, biopharmaceutical contract manufacturing has picked up pace in the recent years. The same is true for the biopharmaceutical contract services market.
Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality
Roots Analysis
AUGUST 29, 2023
Over the last few decades, the development landscape of small molecule drugs has been significantly impacted by various biotechnology breakthroughs. As a result, biopharmaceutical contract manufacturing has picked up pace in the recent years. The same is true for the biopharmaceutical contract services market.
WuXi debuts first vaccine CDMO site in China, where it plans to employ more than 500
Fierce Pharma
SEPTEMBER 26, 2023
WuXi Vaccines launched its first standalone vaccine contract manufacturing facility in Suzhou. With the plant, the company adds drug substance and drug product capacity for projects in various stages of development.
Global Pharmaceutical Contract Manufacturing Market 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com
BioTech 365
DECEMBER 15, 2021
Global Pharmaceutical Contract Manufacturing Market 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com Global Pharmaceutical Contract Manufacturing Market 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)
Non-stop investment from CMOs and US Government into continuous manufacturing
Pharmaceutical Technology
JUNE 23, 2022
In the last year, well-known contract manufacturing organisations (CMOs) such as Agilent Technologies (Santa Clara, California) and Abzena (Cambridge, UK) have expanded their continuous manufacturing capabilities. US Congress is also making substantial investments to improve the continuous manufacturing of pharmaceuticals.
Manufacturing 162
162 
CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders
Pharmaceutical Technology
JULY 29, 2022
In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). The most common marketed drugs in this space aim to address the hyperammonaemia caused by the defective genes in this disorder.
RNA 245
245 
Growing Demand for Oligonucleotides Proposes Shedload of Opportunities for Contract Manufacturers
Roots Analysis
FEBRUARY 18, 2022
The current landscape consists of more than 95 players that claim to offer oligonucleotide contract manufacturing services for research, diagnostic and therapeutic applications. These contract service providers are actively entering into strategic collaborations to augment their existing portfolios. Our Social Media Platform.
AstraZeneca plans to exit 'beating heart' of Indian operations in Bangalore
Fierce Pharma
NOVEMBER 17, 2023
Amid a corporate review of AstraZeneca’s global manufacturing and supply network, the company’s Indian subsidiary is planning to close up shop at the “beating heart” of its India operations in Bang | AstraZeneca Pharma India will exit its production plant in Bangalore, India, “in due course,” the company said in a filing.
Accelerating Oligonucleotide Demand: A Force Driving The Contract Manufacturing Market
Roots Analysis
FEBRUARY 24, 2022
You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and Drug Delivery Systems Market. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link]. Medium: [link]. Pinterest: [link].
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production
The Pharma Data
DECEMBER 15, 2020
This is an important step towards a licensing agreement for Lipidor drug candidates, AKP01 and AKP02, for the treatment of psoriasis. Food and Drug Administration (FDA) for commercial drug production. ” “We look forward to working side by side with Lipidor to be able to offer manufacturing to their future licensees.
Eli Lilly slapped with third FDA rejection in 2023, this time for eczema treatment lebrikizumab
Fierce Pharma
OCTOBER 2, 2023
After laying out a goal to launch four new drugs in 2023, Eli Lilly has run into yet another regulatory snag. | The FDA has rejected Lilly’s investigational atopic dermatitis treatment lebrikizumab over findings uncovered during the inspection of a third-party contract manufacturing organization.
Gilead files COVID-19 drug remdesivir with FDA
pharmaphorum
AUGUST 10, 2020
Gilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the brand name Veklury. The drug is currently available to US patients under an Emergency Use Authorisation for treatment of hospitalised patients with severe COVID-19. Feature image courtesy of Rocky Mountain Laboratories/NIH.
Drugs 99
99 
The rising importance of containment in small molecule drug development
Pharmaceutical Technology
DECEMBER 6, 2022
Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. HPAPIs may now represent more than 30% of the drug development pipeline. Nowadays, you have drugs against cancer which have a very high impact even at a very low dosage.”.
Containment 130
130 
Develop and execute a winning drug launch strategy with an experienced contract packager
Pharmaceutical Technology
JUNE 14, 2023
A GlobalData report which analyzes trends in new drug approvals [i] shows that small molecule approvals have now been surpassed (in 2022) by biologics. Biologics form 51% of the current global drugs pipeline (highest stage of development as pipeline) according to GlobalData’s Drugs database (as of February 7, 2023).
BioSig abandons COVID-19 drug trial on safety concerns
pharmaphorum
OCTOBER 27, 2020
US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt. Moreover, as an orally-active drug merimepodib could also have found a role outside the hospital setting.
Drug Trials 98
98 
Novo Nordisk gets NICE okay for obesity drug Wegovy
pharmaphorum
FEBRUARY 8, 2022
There is a lower threshold for people from south Asian, Chinese, and Black African or Caribbean family backgrounds, who can experience more serious health implications from obesity, typically allowing treatment with drug if the BMI is 2.5 The post Novo Nordisk gets NICE okay for obesity drug Wegovy appeared first on. kg/m2 lower.
Drugs 105
105 
Abiogen acquires EffRx to fortify bone disease portfolio
Pharmaceutical Technology
MAY 30, 2023
Bisphosphonates are drugs that slow the progression of bone loss. EffRx has received several European regulatory approvals for drugs in its portfolio. Alkindi is one of EffRx’s three marketed drugs. In Italy, Abiogen began distributing its bisphosphonates in 2014 and has since seen some successful drug approvals.
FDA rejects Provention’s type 1 diabetes drug teplizumab
pharmaphorum
JULY 7, 2021
Three months ago, the FDA said it was unconvinced by a bridging study designed to show equivalence between Provention’s product intended for commercial sale, made by contract manufacturer AGC Biologics, and the drug that teplizumab’s original developer Eli Lilly used in clinical trials.
Drugs 98
98 
Novo Nordisk maintains strong growth in T2D against competitor Lilly
Pharmaceutical Technology
NOVEMBER 9, 2022
Ozempic has been plagued by a shortage fueled by demand, and Wegovy has had contract-manufacturing-related supply chain issues, but that hasn’t prevented Novo’s GLP-1 franchise from achieving overall sales growth of 44% for the first nine months of the year.
STAT+: Catalent is scolded by FDA for quality control issues at a plant that helps make Covid-19 vaccines
STAT News
SEPTEMBER 21, 2022
Catalent, one of the largest contract manufacturers in the pharmaceutical industry, was cited by the U.S. Food and Drug Administration for a series of quality control failures at a facility in Bloomington, Ind., the same plant where the company helps produce two Covid-19 vaccines.
EU ramps up supply of COVID-19 vaccine, drugs
pharmaphorum
OCTOBER 9, 2020
Meanwhile, the EC has also reached an agreement with Gilead Sciences to secure “rapid and equitable” access to its antiviral drug Veklury (remdesivir) – just as there are reports of shortages emerging around the world. It’s ramped up production capacity internally and through a series of agreements with contract manufacturing partners.
Vaccine 105
105 Leading pharmaceutical solid dose (commercial dose) manufacturing companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 8, 2022
Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.
Manufacturing 100
100 
Eyeing emergency use of COVID-19 drug, Humanigen partners with Lonza to make it
pharmaphorum
SEPTEMBER 15, 2020
Humanigen is hoping for emergency use authorisation in the US for an antibody to treat severe COVID-19 before the end of 2020, and has teamed up with Swiss contract manufacturer Lonza to make sure it can meet demand. They looked at safety as well as carrying out a futility analysis to gauge whether the drug was working as expected.
Drugs 97
97 
CRO NovAliX teams with Bruker to advance drug development
BioPharma Reporter
OCTOBER 29, 2024
In a move set to transform drug discovery, CRO NovAliX has partnered with Bruker, a leader in scientific instruments, through a strategic investment aimed at enhancing drug development success rates.
Development 97
97 
Analyzing the impact of biosimilars on biologic drug manufacturing technologies
Drug Patent Watch
DECEMBER 10, 2024
Biosimilars have been transforming the pharmaceutical landscape by offering cost-effective alternatives to biologic drugs. As patents for these biologics expire, the market for biosimilars is expanding rapidly, with significant implications for manufacturing technologies.
IBM Watson Health, OrbitalRX partner to manage drug shortages
Outsourcing Pharma
SEPTEMBER 8, 2020
The collaboration combines two solutions to help pharma and healthcare providers deal with myriad challenges associated with limited drug supplies.
Drugs 107
107 
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
pharmaphorum
AUGUST 7, 2020
Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other drugs in an effort to fight the pandemic. Pfizer will provide contract manufacturing services at its facility in McPherson, Kansas, to supply the drug to Gilead.
Manufacturing 119
119 
How a specialized commercial program management team can improve your customer experience and accelerate commercialization
Pharmaceutical Technology
MARCH 3, 2023
With over 18 years of experience, Alexander Dragitsch is a commercial customer service contract manufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. The Halle customer service team is a “one-stop-shop” for client requests when it comes to commercial drug product manufacturing,” explains Dragitsch.
Stevanto Group tackling flexible drug containment packages and filling solutions
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Containment 102
102 
(Lopinavir + ritonavir) by Douglas Pharmaceuticals for Genital Warts (Condylomata Acuminata): Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 24, 2023
According to GlobalData, Phase I drugs for Genital Warts (Condylomata Acuminata) have a 91% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
(Lopinavir + ritonavir) by Douglas Pharmaceuticals for Cervical Intraepithelial Neoplasia (CIN): Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 24, 2023
According to GlobalData, Phase I drugs for Cervical Intraepithelial Neoplasia (CIN) have a 92% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Leading commercial dose companies in contract marketing
Pharmaceutical Technology
SEPTEMBER 14, 2022
The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables. Commercial dose companies in contract marketing help in strategically positioning the products in the market, enabling patients to reap maximum benefit from it and transforming its sales management strategies.
Marketing 100
100 
Fluree and Vitality Technet partner to shorten timelines in drug discovery
Outsourcing Pharma
AUGUST 15, 2023
A partnership between technology company Fluree and Vitality TechNet is a âgroundbreaking effortâ to shorten timelines within the drug discovery process.
Drugs 92
92 
Novartis to showcase next-gen manufacturing solutions at BIO 2024
BioPharma Reporter
MAY 15, 2024
Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis Contract Manufacturing.
Let's personalize your content